InnaMed on WeFunder | Deal Review

Apr 20, 2021 1 min read
Invest in InnaMed (YC W17): Using at-home blood testing technology to enable personalized medicine | Wefunder
Using at-home blood testing technology to enable personalized medicine

InnaMed Overview

Problem Addressed: Interfacing with the healthcare system is notoriously challenging. Scheduling appointments, determining insurance coverage, traveling, waiting, testing, scanning, picking up prescriptions, etc.…the list of manual tasks goes on and on.

Solution: InnaMed has reimagined a major part of this journey: the company makes monitoring and analyzing blood test data fast and seamless, while working on a one-stop platform through which users can access and experience digital health services.

Did I Invest In InnaMed?

I’m still in the process of writing a full deal report and decide whether or not I will invest in InnaMed. I review 100+ startups on 10+ platforms every month and send a detailed report every Saturday to subscribers of the Angel Notes newsletter (you can join through the form below). See you soon!

Great! Next, complete checkout for full access to Angel Notes.
Welcome back! You've successfully signed in.
You've successfully subscribed to Angel Notes.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.